Ionis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. 

CEO
Brett P. Monia
CEOBrett P. Monia
Employees
1,069
Employees1,069
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
1989
Founded1989
Employees
1,069
Employees1,069

IONS Key Statistics

Market cap
6.36B
Market cap6.36B
Price-Earnings ratio
-13.24
Price-Earnings ratio-13.24
Dividend yield
Dividend yield
Average volume
2.13M
Average volume2.13M
High today
$40.82
High today$40.82
Low today
$39.72
Low today$39.72
Open price
$40.32
Open price$40.32
Volume
3.27M
Volume3.27M
52 Week high
$52.34
52 Week high$52.34
52 Week low
$23.95
52 Week low$23.95

IONS News

TipRanks 1d
Ionis Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays

Barclays upgraded Ionis Pharmaceuticals (IONS) to Overweight from Equal Weight with a price target of $57, up from $51, ahead of Tryngolza Phase 3 CORE/CORE2 da...

Analyst ratings

71%

of 28 ratings
Buy
71.4%
Hold
25%
Sell
3.6%

People also own

Based on the portfolios of people who own IONS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.